Southeast Asia Dose Optimization of Tafenoquine

NCT04704999 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Plasmodium Vivax Malaria

Interventions

DRUG: Tafenoquine
DRUG: Chloroquine
DRUG: Artemether 20 mg-Lumefantrine 120 mg

Sponsor

University of Oxford